These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 23717519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase.
    Katiyar S, Liu E, Knutzen CA, Lang ES, Lombardo CR, Sankar S, Toth JI, Petroski MD, Ronai Z, Chiang GG.
    EMBO Rep; 2009 Aug; 10(8):866-72. PubMed ID: 19557001
    [Abstract] [Full Text] [Related]

  • 3. REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.
    Dennis MD, Coleman CS, Berg A, Jefferson LS, Kimball SR.
    Sci Signal; 2014 Jul 22; 7(335):ra68. PubMed ID: 25056877
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis.
    Zhao Y, Xiong X, Jia L, Sun Y.
    Cell Death Dis; 2012 Sep 06; 3(9):e386. PubMed ID: 22951983
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1).
    Dennis MD, McGhee NK, Jefferson LS, Kimball SR.
    Cell Signal; 2013 Dec 06; 25(12):2709-16. PubMed ID: 24018049
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structural analysis and functional implications of the negative mTORC1 regulator REDD1.
    Vega-Rubin-de-Celis S, Abdallah Z, Kinch L, Grishin NV, Brugarolas J, Zhang X.
    Biochemistry; 2010 Mar 23; 49(11):2491-501. PubMed ID: 20166753
    [Abstract] [Full Text] [Related]

  • 18. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents.
    Dennis MD, Kimball SR, Fort PE, Jefferson LS.
    J Biol Chem; 2015 Feb 06; 290(6):3865-74. PubMed ID: 25548280
    [Abstract] [Full Text] [Related]

  • 19. Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth.
    Koo J, Yue P, Gal AA, Khuri FR, Sun SY.
    Cancer Res; 2014 May 01; 74(9):2555-68. PubMed ID: 24626091
    [Abstract] [Full Text] [Related]

  • 20. REDD1 is essential for stress-induced synaptic loss and depressive behavior.
    Ota KT, Liu RJ, Voleti B, Maldonado-Aviles JG, Duric V, Iwata M, Dutheil S, Duman C, Boikess S, Lewis DA, Stockmeier CA, DiLeone RJ, Rex C, Aghajanian GK, Duman RS.
    Nat Med; 2014 May 01; 20(5):531-5. PubMed ID: 24728411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.